Hirotsu Bio Science has decided to apply measures based on government policies and action plans.
We have received a request from some of the clinics which handle N-NOSE to postpone/ suspend the implementation of the test. (for the details, please directly confirm with clinics).
In our inspection center, for the safety of the employees, it is planned to decrease its activities.
Hirotsu Bio Science will continue to prioritize the prevention of the spread of the new coronavirus infection both inside and outside of the company and ensure the safety of its employees and business partners.
Thank you for your understanding.
We as HIROTSU Bio Science Inc. (Head Office: Chiyoda-ku, Tokyo; Representative: Takaaki Hirotsu (Hereinafter referred to as “HIROTSU”) are pleas . . .
2024.04.01On March 18, 2024, an reveiw articles on cancer screening by a third-party research team (Romania) was published in "Cancers", an oncology journ . . .
2024.03.29HIROTSU Bioscience Inc. (Head Office: Chiyoda-ku, Tokyo, Representative: Takaaki Hirotsu, hereinafter referred to as “HIROTSU) has verified the . . .
2024.02.29